PRNP and juvenile Huntington disease: In fact, we confirmed that the protective effect of rapamycin in Huntington disease mouse models [56] also translated to an improved survival and reduced plaque deposition in our Tg (PrP-A116V) mouse model of genetic prion disease [13].